Mantle cell: Lymphoma has a broad range of expected survival. The minority of patients have an indolent course, and may not even require therapy at the time of diagnosis. More commonly treatment is initiated with moderate to aggressive chemotherapy with duration of benefit on the order of 3-5 years. With recurrence the management can be more challenging.
Answered 10/4/2018
5.4k views
MIPI: This is imperfect, but this calculator can be uesd to determine prognosis in mantle cell lymphoma (mcl). Mcl international prognostic index (mipi): https://www.Qxmd.Com/calculate-online/hematology/prognosis-mantle-cell-lymphoma-mipi -- additional supportive and treatment options may improve these numbers.
Answered 8/14/2020
5.4k views
A doctor has provided 1 answer
4 doctors weighed in across 2 answers
A doctor has provided 1 answer
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question